Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Quetiapine | |
| Synonyms |
|
|
| Definitions |
A dibenzothiazepine derivative with antipsychotic property. Quetiapine fumarate antagonizes serotonin activity mediated by 5-HT 1A and 5-HT2 receptors. With a lower affinity, this agent also reversibly binds to dopamine D1 and D2 receptors in the mesolimbic and mesocortical areas of the brain leading to decreased psychotic effects, such as hallucinations and delusions. In addition, quetiapine also binds to other alpha-1, alpha-2 adrenergic and histamine H1 receptors. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C61917 |
|
| CAS_Registry |
111974-69-7
|
|
| CHEBI_ID |
CHEBI:8707
|
|
| Chemical_Formula |
C21H25N3O2S
|
|
| code |
C61917
|
|
| Contributing_Source |
FDA
|
|
| definition |
A dibenzothiazepine derivative with antipsychotic property. Quetiapine fumarate antagonizes serotonin activity mediated by 5-HT 1A and 5-HT2 receptors. With a lower affinity, this agent also reversibly binds to dopamine D1 and D2 receptors in the mesolimbic and mesocortical areas of the brain leading to decreased psychotic effects, such as hallucinations and delusions. In addition, quetiapine also binds to other alpha-1, alpha-2 adrenergic and histamine H1 receptors.
|
|
| FDA_UNII_Code |
BGL0JSY5SI
|
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Quetiapine
|
|
| Legacy Concept Name |
Quetiapine
|
|
| Preferred_Name |
Quetiapine
|
|
| prefixIRI |
NCIT:C61917
|
|
| prefLabel |
Quetiapine
|
|
| Semantic_Type |
Pharmacologic Substance
|
|
| UMLS_CUI |
C0123091
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping